Gynecomastia Procedures Market
Gynecomastia Procedures Market Forecasts to 2030 - Global Analysis By Procedure Type (Excision, Liposuction, Mastectomy and Minimal Incision Technique), End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $898.3 MN |
|
Projected Year Value (2030) |
US $1,841.7 MN |
|
CAGR (2023 - 2030) |
10.8% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Gynecomastia Procedures Market is accounted for $898.3 million in 2023 and is expected to reach $1,841.7 million by 2030 growing at a CAGR of 10.8% during the forecast period. Gynecomastia, or male breast enlargement, can be brought on by hormone imbalances, certain drugs, obesity, or other medical disorders. Surgical techniques known as gynecomastia operations are designed to help men achieve a more manly and sculpted chest look by removing extra breast tissue. People should speak with a licensed plastic surgeon or other healthcare provider before having any operation done in order to determine the best course of action for their particular situation and desired results.
Market Dynamics:
Driver:
Increasing awareness and acceptance
As gynecomastia becomes better known, more people who are impacted by it learn about their choices for treatment. As more people seek medical intervention to address their worries about appearance and the psychological effects that go along with it, there is a greater demand for gynecomastia operations as a result of this heightened knowledge. Insurance companies and healthcare systems may change to provide coverage for gynecomastia operations. A wider group of people may find these therapies more inexpensive and accessible with improved insurance coverage or financing alternatives driving the growth of the market.
Restraint:
High procedure costs
When it comes to elective operations, patients' decisions are heavily influenced by affordability. Exorbitant expenses may cause patients to seek fewer gynecomastia operations, which would have an impact on the market if people choose not to pursue therapy because of budgetary difficulties. Thus health disparities may be exacerbated by differences in access to gynecomastia treatments brought on by exorbitant pricing. Healthcare disparities may be exacerbated for members of marginalized or economically poor populations who may find it difficult to obtain critical treatments.
Opportunity:
Advancements in medical technology
New gynecomastia treatment approaches are being investigated and developed as a result of ongoing breakthroughs in medical technology. This covers the application of ultrasonic energy, radiofrequency-assisted devices, and other cutting-edge technologies that seek to offer complementary or alternative strategies to conventional surgical techniques. Moreover, patients in rural locations or places with limited access to specialized healthcare facilities now have more access to expert views and consultations thanks to telemedicine and teleconsultation. For those with gynecomastia, this wider reach improves access to information and possible therapies.
Threat:
Cultural stigma and perception
People who are affected with gynecomastia may put off seeking medical attention out of stigma and cultural preconceptions because they are afraid of being judged or embarrassed. Delays can make the illness worse and have an adverse effect on people's physical and emotional health. Lack of knowledge or acceptance of gynecomastia as a legitimate medical problem which is a medically curable condition that many people may be unaware of, which might result in underreporting and a decline in the demand for operations thus hamper the growth of the market.
Covid-19 Impact
In order to concentrate resources for COVID-19 patients, numerous elective operations, including gynecomastia treatments, were postponed or cancelled during the height of the pandemic. In an effort to save medical resources and lower the danger of virus transmission, hospitals and clinics were instructed to restrict the number of unnecessary procedures. Global healthcare systems directed their attention and resources away from elective surgery, such as gynecomastia treatments, in order to manage and control the virus's spread.
The liposuction segment is expected to be the largest during the forecast period
The liposuction segment is estimated to have a lucrative growth, as liposuction is a popular surgical method used to treat cases where the buildup of extra fat is the main cause of male breast enlargement. Liposuction is a popular and successful method in the market for gynecomastia procedures, particularly in situations where the buildup of extra fat is the primary cause of gynecomastia. However, in order to choose the best course of action based on each patient's unique situation and desired results, it is imperative to speak with a licensed plastic surgeon or other healthcare professional.
The cosmetic surgical centers segment is expected to have the highest CAGR during the forecast period
The cosmetic surgical centers segment is anticipated to witness the highest CAGR growth during the forecast period, Cosmetic surgery facilities provide unique operations catered to the specific requirements of each customer. These might involve liposuction, excision of glandular tissue, endoscopic procedures, or a mix of methods according to the patient's condition. Board-certified cosmetic surgeons and medical professionals skilled in gynecomastia treatments work at these clinics. They guarantee the best possible results, patient safety, and professional standards compliance. Throughout the course of therapy, they keep a discreet and professional atmosphere, placing a high value on patient privacy and confidentiality.
Region with largest share:
North America is projected to hold the largest market share during the forecast period owing to the sophisticated healthcare infrastructure, strict regulations, focus on patient safety and quality of care and presence of important companies are the drivers driving the regional expansion. Furthermore, people can seek gynecomastia therapies more easily due to the increased accessibility to healthcare facilities and comparatively larger disposable expenditures. The rivalry in this sector further solidifies the region's supremacy by fostering innovation and ensuring a high level of treatment driving the growth of the market in this region.
Region with highest CAGR:
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to rising knowledge of gynecomastia and its treatment choices is developing in the Asia Pacific area, so the stigma associated with gynecomastia is progressively disappearing, leading to more acceptability and a stronger demand for therapies. In addition, the Asia Pacific area has had notable economic expansion in recent times, which has led to a rise in the population's disposable income, hence augmenting market expansion in the area.
Key players in the market
Some of the key players profiled in the Gynecomastia Procedures Market include Sun Pharmaceuticals Industries Ltd, Cadila Pharmaceuticals Ltd, Biochem Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Micro Nova Pharmaceuticals Ltd, Kee Pharma Ltd, Dr. Reddy's Laboratories Ltd, Vyaire Medical, MicroAire Surgical Instruments, Bausch Health Companies, Stryker Corporation, Lumenis, Johnson & Johnson, Cutera, GALDERMA, Cynosure and AbbVie Inc.
Key Developments:
In December 2023, AbbVie Inc. and Cerevel Therapeutics announced a definitive agreement under which AbbVie will acquire Cerevel Therapeutics and its robust neuroscience pipeline
In November 2023, Johnson & Johnson MedTech1 announced the completion of the acquisition2 of Laminar, Inc., a privately-held medical device company focused on eliminating the left atrial appendage (LAA) in patients with non-valvular atrial fibrillation (AFib).
In July 2023, Cadila Pharma launches Posaconazole for treatment of fungal diseases, The drug has also been recommended as a second line treatment for Mucormycosis or black fungus as it is commonly known.
Procedure Types Covered:
• Excision
• Liposuction
• Mastectomy
• Minimal Incision Technique
End Users Covered:
• Cosmetic Surgical Centers
• Hospitals
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Gynecomastia Procedures Market, By Procedure Type
5.1 Introduction
5.2 Excision
5.3 Liposuction
5.4 Mastectomy
5.5 Minimal Incision Technique
6 Global Gynecomastia Procedures Market, By End User
6.1 Introduction
6.2 Cosmetic Surgical Centers
6.3 Hospitals
7 Global Gynecomastia Procedures Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa
8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies
9 Company Profiling
9.1 Sun Pharmaceuticals Industries Ltd
9.2 Cadila Pharmaceuticals Ltd
9.3 Biochem Pharmaceutical Industries Ltd
9.4 Zydus Cadila Healthcare Ltd
9.5 Micro Nova Pharmaceuticals Ltd
9.6 Kee Pharma Ltd
9.7 Dr. Reddy's Laboratories Ltd
9.8 Vyaire Medical
9.9 MicroAire Surgical Instruments
9.10 Bausch Health Companies
9.11 Stryker Corporation
9.12 Lumenis
9.13 Johnson & Johnson
9.14 Cutera
9.15 GALDERMA
9.16 Cynosure
9.17 AbbVie Inc.
List of Tables
1 Global Gynecomastia Procedures Market Outlook, By Region (2021-2030) ($MN)
2 Global Gynecomastia Procedures Market Outlook, By Procedure Type (2021-2030) ($MN)
3 Global Gynecomastia Procedures Market Outlook, By Excision (2021-2030) ($MN)
4 Global Gynecomastia Procedures Market Outlook, By Liposuction (2021-2030) ($MN)
5 Global Gynecomastia Procedures Market Outlook, By Mastectomy (2021-2030) ($MN)
6 Global Gynecomastia Procedures Market Outlook, By Minimal Incision Technique (2021-2030) ($MN)
7 Global Gynecomastia Procedures Market Outlook, By End User (2021-2030) ($MN)
8 Global Gynecomastia Procedures Market Outlook, By Cosmetic Surgical Centers (2021-2030) ($MN)
9 Global Gynecomastia Procedures Market Outlook, By Hospitals (2021-2030) ($MN)
10 North America Gynecomastia Procedures Market Outlook, By Country (2021-2030) ($MN)
11 North America Gynecomastia Procedures Market Outlook, By Procedure Type (2021-2030) ($MN)
12 North America Gynecomastia Procedures Market Outlook, By Excision (2021-2030) ($MN)
13 North America Gynecomastia Procedures Market Outlook, By Liposuction (2021-2030) ($MN)
14 North America Gynecomastia Procedures Market Outlook, By Mastectomy (2021-2030) ($MN)
15 North America Gynecomastia Procedures Market Outlook, By Minimal Incision Technique (2021-2030) ($MN)
16 North America Gynecomastia Procedures Market Outlook, By End User (2021-2030) ($MN)
17 North America Gynecomastia Procedures Market Outlook, By Cosmetic Surgical Centers (2021-2030) ($MN)
18 North America Gynecomastia Procedures Market Outlook, By Hospitals (2021-2030) ($MN)
19 Europe Gynecomastia Procedures Market Outlook, By Country (2021-2030) ($MN)
20 Europe Gynecomastia Procedures Market Outlook, By Procedure Type (2021-2030) ($MN)
21 Europe Gynecomastia Procedures Market Outlook, By Excision (2021-2030) ($MN)
22 Europe Gynecomastia Procedures Market Outlook, By Liposuction (2021-2030) ($MN)
23 Europe Gynecomastia Procedures Market Outlook, By Mastectomy (2021-2030) ($MN)
24 Europe Gynecomastia Procedures Market Outlook, By Minimal Incision Technique (2021-2030) ($MN)
25 Europe Gynecomastia Procedures Market Outlook, By End User (2021-2030) ($MN)
26 Europe Gynecomastia Procedures Market Outlook, By Cosmetic Surgical Centers (2021-2030) ($MN)
27 Europe Gynecomastia Procedures Market Outlook, By Hospitals (2021-2030) ($MN)
28 Asia Pacific Gynecomastia Procedures Market Outlook, By Country (2021-2030) ($MN)
29 Asia Pacific Gynecomastia Procedures Market Outlook, By Procedure Type (2021-2030) ($MN)
30 Asia Pacific Gynecomastia Procedures Market Outlook, By Excision (2021-2030) ($MN)
31 Asia Pacific Gynecomastia Procedures Market Outlook, By Liposuction (2021-2030) ($MN)
32 Asia Pacific Gynecomastia Procedures Market Outlook, By Mastectomy (2021-2030) ($MN)
33 Asia Pacific Gynecomastia Procedures Market Outlook, By Minimal Incision Technique (2021-2030) ($MN)
34 Asia Pacific Gynecomastia Procedures Market Outlook, By End User (2021-2030) ($MN)
35 Asia Pacific Gynecomastia Procedures Market Outlook, By Cosmetic Surgical Centers (2021-2030) ($MN)
36 Asia Pacific Gynecomastia Procedures Market Outlook, By Hospitals (2021-2030) ($MN)
37 South America Gynecomastia Procedures Market Outlook, By Country (2021-2030) ($MN)
38 South America Gynecomastia Procedures Market Outlook, By Procedure Type (2021-2030) ($MN)
39 South America Gynecomastia Procedures Market Outlook, By Excision (2021-2030) ($MN)
40 South America Gynecomastia Procedures Market Outlook, By Liposuction (2021-2030) ($MN)
41 South America Gynecomastia Procedures Market Outlook, By Mastectomy (2021-2030) ($MN)
42 South America Gynecomastia Procedures Market Outlook, By Minimal Incision Technique (2021-2030) ($MN)
43 South America Gynecomastia Procedures Market Outlook, By End User (2021-2030) ($MN)
44 South America Gynecomastia Procedures Market Outlook, By Cosmetic Surgical Centers (2021-2030) ($MN)
45 South America Gynecomastia Procedures Market Outlook, By Hospitals (2021-2030) ($MN)
46 Middle East & Africa Gynecomastia Procedures Market Outlook, By Country (2021-2030) ($MN)
47 Middle East & Africa Gynecomastia Procedures Market Outlook, By Procedure Type (2021-2030) ($MN)
48 Middle East & Africa Gynecomastia Procedures Market Outlook, By Excision (2021-2030) ($MN)
49 Middle East & Africa Gynecomastia Procedures Market Outlook, By Liposuction (2021-2030) ($MN)
50 Middle East & Africa Gynecomastia Procedures Market Outlook, By Mastectomy (2021-2030) ($MN)
51 Middle East & Africa Gynecomastia Procedures Market Outlook, By Minimal Incision Technique (2021-2030) ($MN)
52 Middle East & Africa Gynecomastia Procedures Market Outlook, By End User (2021-2030) ($MN)
53 Middle East & Africa Gynecomastia Procedures Market Outlook, By Cosmetic Surgical Centers (2021-2030) ($MN)
54 Middle East & Africa Gynecomastia Procedures Market Outlook, By Hospitals (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
